Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 643 entries
View as:

PSMA-PET/CT for Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03558711 Org: User:
Start: 01/04/18 End: 03/29/18 Due: 03/29/19

Factors Associated with Falling in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04440033 Org: User:
Start: 10/12/20 End: 12/01/23 Due: 12/01/24

Optimizing Ovarian Stimulation for IVF and ICSI

Phase: N/A Priority: Normal
NCT ID: NCT01980563 Org: User:
Start: 01/31/11 End: 12/31/12 Due: 12/31/13

COMplete Versus PArtial Open inCisional Hernia Repair (COMPAC-TRIAL)

Phase: N/A Priority: Normal
NCT ID: NCT00498810 Org: User:
Start: 09/30/07 End: 01/31/08 Due: 01/31/09

Physical Activity Coaching After Surgery for Patients with Resectable Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06057766 Org: User:
Start: 01/01/24 End: 06/01/25 Due: 06/01/26

Incontinence and MRI Results in Children with Cerebral Palsy

Phase: N/A Priority: Normal
NCT ID: NCT05060211 Org: User:
Start: 10/25/21 End: 06/30/23 Due: 06/30/24

Muscle and Bone in Patients with Diabetes Mellitus and Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT06519942 Org: User:
Start: 12/12/23 End: 11/30/25 Due: 11/30/26

Immunological Mechanisms Underlying Mucosal IgE Responses

Phase: N/A Priority: Normal
NCT ID: NCT06234761 Org: User:
Start: 01/02/24 End: 12/31/28 Due: 12/31/29

Rapid Antimicrobial Susceptibility Testing with MIC Directly from Positive Blood Cultures with ASTar

Phase: N/A Priority: Normal
NCT ID: NCT06218277 Org: User:
Start: 01/10/24 End: 08/31/24 Due: 08/31/25

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis from Gastrointestinal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05277766 Org: User:
Start: 11/21/22 End: 01/01/27 Due: 01/01/28

Hyperalgesia, Persistent Pain, and Fentanyl Dosing in On-Pump Coronary Artery Bypass Grafting

Phase: N/A Priority: Normal
NCT ID: NCT03450161 Org: User:
Start: 05/14/18 End: 01/09/21 Due: 01/09/22

Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02826564 Org: User:
Start: 11/14/16 End: 02/18/19 Due: 02/18/20

Evaluation of Mesh Integration and Mesh Contraction After Open Preperitoneal Inguinal Hernia Repair Using a Memory Ring Containing Device

Phase: N/A Priority: Normal
NCT ID: NCT01622712 Org: User:
Start: 02/01/13 End: 09/02/14 Due: 09/02/15

Food and Salt Handling in Diuresis

Phase: N/A Priority: Normal
NCT ID: NCT04526340 Org: User:
Start: 06/24/19 End: 02/28/22 Due: 02/28/23

Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients.

Phase: N/A Priority: Normal
NCT ID: NCT03747562 Org: User:
Start: 03/01/19 End: 07/01/22 Due: 07/01/23

Therapeutic Drug Monitoring of Guselkumab in Psoriasis Patients

Phase: N/A Priority: Normal
NCT ID: NCT04080648 Org: User:
Start: 06/27/18 End: 12/31/23 Due: 12/31/24

Family Involvement in CBGT of OCD: a Randomized Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT04071990 Org: User:
Start: 09/03/19 End: 12/31/25 Due: 12/31/26

Patient-specific Planning of Minimally Invasive Brain Interventions Based on Vascular-hemodynamic Mapping

Phase: N/A Priority: Normal
NCT ID: NCT06588543 Org: User:
Start: 08/13/24 End: 12/31/30 Due: 12/31/31

Analysis of the Reservoir in Individuals Controlling HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT06016114 Org: User:
Start: 12/01/24 End: 10/01/28 Due: 10/01/29

Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous Infusion

Phase: N/A Priority: Normal
NCT ID: NCT01198925 Org: User:
Start: 09/23/10 End: 05/03/18 Due: 05/03/19

MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04082182 Org: User:
Start: 08/26/19 End: 12/31/21 Due: 12/31/22

Multicentric, Prospective, Randomized, Comparing Trial Between Bypass of the Femoropoplitea by PTFE and Heparin Bounded PTFE

Phase: N/A Priority: Normal
NCT ID: NCT00147979 Org: User:
Start: 04/30/04 End: 08/31/13 Due: 08/31/14

Switching From Adalimumab to Infliximab

Phase: N/A Priority: Normal
NCT ID: NCT01338740 Org: User:
Start: 04/30/11 End: 02/17/14 Due: 02/17/15

Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT00372307 Org: User:
Start: 05/31/04 End: 11/30/04 Due: 11/30/05

Olfactive Discriminative Ability of Dogs When Confronted With Seizure and Non-seizure Samples // Identification of Potential Biomarkers for Epilepsy in Human Sweat.

Phase: N/A Priority: Normal
NCT ID: NCT04266990 Org: User:
Start: 01/20/20 End: 03/13/20 Due: 03/13/21